Kuros announces results of Rights Offering
Kuros Biosciences (SIX: KURN) (the Company or Kuros) announces the results of its Rights Offering, first announced on Oc…
Kuros Biosciences (SIX: KURN) (the Company or Kuros) announces the results of its Rights Offering, first announced on Oc…
Kuros Biosciences (SIX: KURN) (the Company or Kuros) announces the final number of Offered Shares and gross proceeds fro…
Kuros Biosciences (SIX: KURN) (the Company or Kuros) announces the results of the Rights Offering, first announced on No…
Kuros Biosciences (SIX: KURN) (the Company or Kuros) has obtained on November 28, 2019 after market close a binding orde…
Kuros Biosciences (SIX: KURN) (the Company or Kuros) at today’s Extraordinary General Meeting (EGM) of shareholders will…
Kuros Biosciences (SIX: KURN) (the Company or Kuros) announces the final number of offered shares and gross proceeds fro…
Kuros Biosciences (SIX: KURN) (the Company or Kuros) at today’s Extraordinary General Meeting (EGM) of shareholders will…
Kuros Biosciences (SIX: KURN) (the Company) today announced that it will hold an Extraordinary General Meeting (EGM) of…
Kuros Biosciences (SIX:KURN) gibt bekannt, dass die der Zürcher Kantonalbank gewährte Mehrzuteilungsoption im Zusammenha…
Kuros Biosciences (SIX:KURN) gibt bekannt, dass das Unternehmen 1‘151‘606 neue Aktien (exklusive einer Mehrzuteilungsopt…